Curative Effect of Recombinate Erythropoietin Administered by Different Routes for Patients Receiving Hemodialysis
- VernacularTitle:重组人促红细胞生成素不同给药途径对血液透析患者的疗效观察
- Author:
Zhiyi HE
;
Yanping WU
- Publication Type:Journal Article
- Keywords:
Hemodialysis;
r-HuEPO;
Subcutaneous injection;
Intravenous injection;
Hypertension
- From:
China Pharmacy
2005;0(23):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To evaluate the curative efficacy of recombinate erythropoietin(r-HuEPO) administered through different route for patients receiving hemodialysis.METHODS: 40 patients undergoing maintenance hemodialysis(MHD) were randomized into subcutaneous injection group and intravenous injection group.The hemoglobin(Hb),hematokrit(Hct) and the adverse effect within 12 weeks were observed.RESULTS: The Hb/Hct level of the two groups increased with the prolonging of treatment,which increased significantly at 8 weeks and 12 weeks as compared with before treatment(P
